Mesh结构P/G布线网络层次化快速分析方法

本文提出了一个基于网络划分的P／G布线网络层次化快速分析方法。其中，对于子网运算，通过对Cholesky分解法三角化对称正定阵的图模型分析，并基于Mesh结构网络的自身特点，提出了一个基于图顶点排序的加速子网分析运算策略；并用基于MPI的并行结构实现了P／G布线网络分析的并行运算。     

无源性理论在永磁同步电动机混沌控制中的应用

永磁同步电动机在一定的工作条件下呈现出混沌运动，根据无源性网络理论，设计电动机混沌动力学模型的控制器，将混沌系统等效为无源系统，消除系统中的混沌运动，降低系统自激振动的危害，实现混沌系统的快速稳定。     

Mesh-Tree两级层次结构P/G网布线优化方法

本文采用Mesh-Tree两级层次结构作为P／G网布线拓扑结构，并提出了一个对于该结构的线宽优化方法，使超大型P／G网的布线优化速度大大提高。     

街面水电站混凝土面板堆石坝主要技术问题探讨

街面水电站拦河坝为混凝土面板堆石坝,在面板止水结构型式、面板防裂措施、上游面的施工方法、趾板开挖处理及趾板灌浆等方面,根据工程实际情况,结合国内外的新技术新工艺进行了探讨。     

IF板与08Al板的成形性能研究

通过模拟成形性试验，对新型超深冲用IF钢板和传统冲压用08Al钢板的冲压成形性能进行了研究．结果表明：IF板的拉深性能、扩孔性能、胀形性能以及“拉深-胀形”复合性能等均优于08Al板，其中，扩孔性能和平面各向异性的改善最为显著；各项试验中，IF板的成形力普遍小于08Al板。     

溶胶-凝胶法制备Li（MoO4）2：Eu及表征

用溶胶-凝胶法制备了平均粒径为2～3μm的小颗粒、高亮度的Li（2-x）（MoO4）2：Eu系列钼酸盐红色荧光体。用XRD、SEM、粒度分析和分子荧光光度计对荧光体进行了表征和研究。常规的固相反应合成Li（2-x）（MoO4）2：Eux系列红色荧光粉需要在900℃以上的高温才能够形成均一的固溶体，而采用溶胶-凝胶法制取，在700℃就可以形成均一的单相Li（2-x）（MoO4）2：Eux，在750℃就可得到发光亮度最高的荧光体。其亮度是常规固相反应于900℃制得的荧光体的124％。采用溶胶-凝胶法制取Li（2-x）（MoO4）2：Eux系列，可以在相当宽的实验条件范围内得到小粒径、窄分布和高亮度的荧光体，具有良好的颗粒形貌。     

Simulating Experiment for Temperature Field of Frozen Subgrade Using Regulation Tubes

The main factors that influence the temperature field of frozen subgrade were analyzed.The experimental equipment for simulating frozen subgrade was built up,and the declining regulating tubes were placed at the foot of the embankment. By means of this equipment two simulating experiments of controlling temperature filed of frozen subgrade were carried out in the laboratory. One method is to collect natural cold energy, and the other one is to collect natural cold energy ccompanied by artificial refrigeration simultaneously. The result indicates that the latter is an effective method for maintaining the stability of the frozen subgrade.     

Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop

The chemokine receptor CCR5 acts as an essential cofactor for cell entry by macrophage-tropic human immunodeficiency virus type 1 (HIV-1) strains, whereas CXCR4 acts as an essential cofactor for T-cell-line-adapted strains. We demonstrated that the specific amino acids in the V3 loop of the HIV-1 envelope protein that determine cellular tropism also regulate chemokine coreceptor preference for cell entry by the virus. Further, a strong correlation was found between HIV-1 strains classified as syncytium inducing in standard assays and those using CXCR4 as a coreceptor. These data support the hypothesis that progressive adaptation to additional coreceptors is a key molecular basis for HIV-1 phenotypic evolution in vivo.     

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy

The aim of our study was to evaluate whether inhibition of ACE (lisinopril 10-20 mg/day) can reduce the rate of decline in kidney function more than reducing blood pressure with conventional antihypertensive treatment (atenolol 50-100 mg/day), usually in combination with a diuretic. We performed a prospective, randomized, parallel study for 42 months, double blind for the first 12 months and single blind thereafter. Forty-three (21 lisinopril and 22 atenolol) hypertensive NIDDM patients with diabetic nephropathy were enrolled. Data from 36 patients (17 lisinopril and 19 atenolol, 60 +/- 7 years of age, 27 men) who completed at least 12 months of the study period are presented. At baseline, the two groups were comparable: glomerular filtration rate (51Cr-EDTA plasma clearance) was 75 +/- 6 and 74 +/- 8 ml x min(-1) x 1.73 m(-2), mean 24-h ambulatory blood pressure (A&D TM2420) was 110 +/- 3 and 114 +/- 2 mmHg, and 24-h urinary albumin excretion rate was 961 (range 331-5,727) and 1,578 (476-5,806) mg/24 h in the lisinopril and atenolol groups, respectively. The mean follow-up time was similar, 37 and 35 months in the lisinopril and atenolol groups, respectively. Mean ambulatory blood pressure was equally reduced in the two groups, 12 +/- 2 and 10 +/- 2 mmHg in the lisinopril and atenolol groups, respectively. Glomerular filtration rate declined in a biphasic manner with a faster initial (0 to 6 months) change of 1.25 +/- 0.49 and 0.81 +/- 0.29 ml x min(-1) x month(-1) followed by a slower sustained decline (6 to 42 months) of 0.59 +/- 0.10 and 0.54 +/- 0.13 ml x min(-1) x month(-1) in the lisinopril and atenolol groups, respectively. No significant differences were observed in either initial or sustained decline in glomerular filtration rate between the two groups. Urinary albumin excretion was reduced (% reduction of baseline) more in the lisinopril than in the atenolol group, at 55 (95% CI 29-72) and 15% (-13 to 34), respectively (P = 0.01). In conclusion, the relentless decline in kidney function characteristically found in hypertensive NIDDM patients with diabetic nephropathy can be reduced equally effectively by two antihypertensive treatments, the beta-blocker atenolol and the ACE inhibitor lisinopril.     

Metastatic parathyroid carcinoma in the MEN2A syndrome

We report a patient with a metastatic parathyroid carcinoma and medullary carcinoma of the thyroid. This patient represents a variation of the multiple endocrine neoplasia syndrome (MEN) type 2A. There was no evidence of a phaeochromocytoma. The case illustrates the difficulties that may be encountered in localising the source of PTH secretion; the patient underwent four unsuccessful exploratory operations of the neck and mediastinum before further investigations revealed a single metastatic deposit of parathyroid carcinoma involving the first thoracic vertebra. PCR amplification and sequencing of the RET oncogene from the metastatic parathyroid carcinoma and genomic DNA revealed a heterozygous mutation (Cys634Tyr) in exon 11, as has previously been described to occur in MEN 2A. In addition, loss of tumour heterozygosity was demonstrated at loci from chromosomes 1, 2, 3p, 13q and 16p. This represents the first report of a parathyroid carcinoma in a MEN2A patient, in which the multiple allelic deletions are consistent with the generalised losses observed in aggressive tumours.